PB1925: VENETOCLAX IN COMBINATION WITH AZACITIDINE OR LOW-DOSE CYTARABINE IN PATIENTS WITH HIGH-RISK MDS AND AML - EXPERIENCE OF A CZECH HAEMATOLOGY CENTRE.
L. Minarik,
T. Stopka,
Z. Zemanova,
A. Jonasova
Affiliations
L. Minarik
1 Clinic of Hematology, General University Hospital and First Faculty of Medicine, Charles University, Prague
T. Stopka
1 Clinic of Hematology, General University Hospital and First Faculty of Medicine, Charles University, Prague
Z. Zemanova
3 Center of Oncocytogenomics, Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czechia
A. Jonasova
1 Clinic of Hematology, General University Hospital and First Faculty of Medicine, Charles University, Prague
